Tandem Diabetes Care (TNDM) Finished Goods (2014 - 2019)

Tandem Diabetes Care has reported Finished Goods for 6 years, with the latest figure at $9.7 million in Q1 2019.

• For the quarter ending Q1 2019, Finished Goods fell 21.48% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2019 stood at $9.7 million (down 21.48% YoY), and the FY2018 full-year result was $10.6 million, down 17.81% from the prior year.
• Finished Goods for Q1 2019 stood at $9.7 million, down from $10.6 million in the prior quarter.
• The five-year high for Finished Goods was $14.4 million in Q3 2017, with the low at $2.9 million in Q2 2015.
• Historically, Finished Goods has averaged $8.5 million across 5 years, with a median of $9.1 million in 2016.
• Annual changes were most pronounced in 2016 — Finished Goods surged 145.5% — and 2019, when it slipped 21.48%.
• Tandem Diabetes Care's Finished Goods stood at $3.5 million in 2015, then surged by 109.57% to $7.4 million in 2016, then soared by 73.1% to $12.9 million in 2017, then decreased by 17.81% to $10.6 million in 2018, then fell by 8.36% to $9.7 million in 2019.
• The last three Finished Goods figures came in at $9.7 million (Q1 2019), $10.6 million (Q4 2018), and $11.3 million (Q3 2018), per Business Quant data.